Translational Oncology
- Biomarker discovery
- Mouse clinical trial
- 61 PDX-derived primary cancer cell lines
- Drug-resistant xenograft models
- Combination therapy platform including radiation
- World leading genome sequencing and bioinformatics capability
translational Oncology 20200513
Related Content
Receptor tyrosine kinase-like orphan receptor 1 (ROR1) is a key mediator of non-canonical Wnt signaling and plays a critical role...
VIEW RESOURCEAt this year’s annual meeting of the American Association for Cancer Research (AACR), WuXi Biology has been selected to present...
VIEW RESOURCE